Endonovo Therapeutics, Inc. financial statements, including revenue, expenses, profit, and loss
The total revenue of ENDV for the last quarter is 0.00 USD, and it's 100.00% lower compared to the previous quarter. The net income of Q3 24 is -697.13 k USD.